Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the European Research Council (ERC), have identified a 14-protein signature in the ...

ABC News’ Dr. Tara Narula explains a discovery that could help doctors predict and prevent the world’s deadliest cancer.

Lung cancer may not be the most common cancer diagnosis in the United States—that would be prostate cancer for men and breast ...

As Ben Franklin once famously said, “An ounce of prevention is worth a pound of cure,” and that adage applies to cancer. February is Cancer Prevention Month, which is the perfect time to reflect on ...

Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung ...

At ASCO 2026, companies debuted data that could hold the potential to disrupt the frontline treatment paradigm for various ...

When Garen was diagnosed with lung cancer, biomarker testing helped focus his treatment options, inform his treatment ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Akeso’s Phase 3 ASCO data show ivonescimab improved overall survival vs PD-1 chemo in squamous NSCLC—key read for investors.

Most lung cancers aren’t diagnosed until you’re older. In fact, on average, lung cancer shows up around the age of 70. The most common type is non-small-cell lung cancer (NSCLC), which grows from the ...